Differential sensitivity of paclitaxel-induced apoptosis in human esophageal squamous cell carcinoma cell lines

[1]  H. Kuwano,et al.  Expression of heat-shock protein Hsp60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinoma. , 2004, European journal of cancer.

[2]  Hideyuki Yamamoto,et al.  The X-linked inhibitor of apoptosis protein inhibits taxol-induced apoptosis in LNCaP cells , 2003, Urological Research.

[3]  T. Toyama,et al.  Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer. , 2002, Carcinogenesis.

[4]  D. Vaux,et al.  The anti-apoptotic activity of XIAP is retained upon mutation of both the caspase 3– and caspase 9–interacting sites , 2002, The Journal of cell biology.

[5]  D. Cyr,et al.  CHIP Is a U-box-dependent E3 Ubiquitin Ligase , 2001, The Journal of Biological Chemistry.

[6]  D. Glineur,et al.  Skeletonizing En Bloc Esophagectomy for Cancer , 2001, Annals of surgery.

[7]  D. Vaux,et al.  Direct inhibition of caspase 3 is dispensable for the anti‐apoptotic activity of XIAP , 2001, The EMBO journal.

[8]  M. Iannettoni,et al.  Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Emad S. Alnemri,et al.  Negative regulation of the Apaf-1 apoptosome by Hsp70 , 2000, Nature Cell Biology.

[10]  Guido Kroemer,et al.  Mitochondrial control of cell death , 2000, Nature Medicine.

[11]  Y Li,et al.  [Mitochondria and apoptosis]. , 2000, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[12]  D. Nicholson,et al.  Caspase structure, proteolytic substrates, and function during apoptotic cell death , 1999, Cell Death and Differentiation.

[13]  B. Zhivotovsky,et al.  Presence of a pre‐apoptotic complex of pro‐caspase‐3, Hsp60 and Hsp10 in the mitochondrial fraction of Jurkat cells , 1999, The EMBO journal.

[14]  P. Tawa,et al.  Hsp60 accelerates the maturation of pro‐caspase‐3 by upstream activator proteases during apoptosis , 1999, The EMBO journal.

[15]  S. Korsmeyer,et al.  Cell Death in Development , 1999, Cell.

[16]  G. Kroemer,et al.  Mitochondria as regulators of apoptosis: doubt no more. , 1998, Biochimica et biophysica acta.

[17]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[18]  Guy S. Salvesen,et al.  X-linked IAP is a direct inhibitor of cell-death proteases , 1997, Nature.

[19]  T. Vu,et al.  Increased Expression of the Insulin-like Growth Factor-II Gene in Wilms' Tumor Is Not Dependent on Loss of Genomic Imprinting or Loss of Heterozygosity* , 1996, The Journal of Biological Chemistry.

[20]  T. Walsh,et al.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. , 1996, The New England journal of medicine.

[21]  A. Chinnaiyan,et al.  ICE-LAP6, a Novel Member of the ICE/Ced-3 Gene Family, Is Activated by the Cytotoxic T Cell Protease Granzyme B* , 1996, The Journal of Biological Chemistry.

[22]  N. Thornberry,et al.  Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death , 1996, The Journal of experimental medicine.

[23]  W. Mcguire,et al.  Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  J. Ajani,et al.  Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. , 1994, Journal of the National Cancer Institute.

[25]  K. L. Donaldson,et al.  Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle , 1994, International journal of cancer.

[26]  M. Untch,et al.  Comparison of paclitaxel and docetaxel (Taxotere) in gynecologic and breast cancer cell lines with the ATP-cell viability assay. , 1994, Anti-cancer drugs.

[27]  S. Hahn,et al.  Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity. , 1993, Cancer research.

[28]  C. Runowicz,et al.  Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  K. Tew,et al.  Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines. , 1992, Cancer research.

[30]  M. Stearns,et al.  Taxol blocks processes essential for prostate tumor cell (PC-3 ML) invasion and metastases. , 1992, Cancer research.

[31]  E. Hall,et al.  Taxol sensitizes human astrocytoma cells to radiation. , 1992, Cancer research.

[32]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[33]  R. Benjamin,et al.  A phase II trial of taxol in metastatic melanoma , 1990, Cancer.

[34]  P. Schiff,et al.  Taxol stabilizes microtubules in mouse fibroblast cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[35]  P. Schiff,et al.  Promotion of microtubule assembly in vitro by taxol , 1979, Nature.

[36]  A. McPhail,et al.  Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. , 1971, Journal of the American Chemical Society.

[37]  T. Kuroki,et al.  Molecular and cellular features of esophageal cancer cells , 2005, Journal of Cancer Research and Clinical Oncology.

[38]  C. Chi,et al.  Paclitaxel‐induced apoptosis in human gastric carcinoma cell lines , 1996, Cancer.